'We care… because care is growth'. The low-tech imaginaries of India's small-scale pharmaceutical enterprises (original) (raw)
Related papers
Journal of Economic Geography, 2022
Global value chain/global production network studies have extensively documented the role of lead firms from the Global North in economic development in the Global South, including as 'manufacturers without factories' (MWFs). However, the role of local firms in sourcing from suppliers has been overlooked. In this article, we report the findings of a qualitative study and demonstrate that the local MWFs helped establish India as the leading supplier of pharmaceuticals worldwide and in the Global South. We show how the different types of local MWFs ('propagandists', 'pioneers', 'connectors' and 'adaptors') impact the strategic coupling, industrial upgrading and governance in South-South value chains and contribute to regional economic development.
Indian Pharma: A Global Leader Under Pressure
2020
India is a global supplier of generic drugs. Its export-oriented pharmaceutical industry is extremely profitable but encounters a number of challenges, from domestic demand to human resources. The Covid-19 pandemic has brought to light its dependence on imports from China of active pharmaceutical ingredients and chemical intermediates. As the whole world discusses how to increase the resilience of supply chains, could this be an opportunity for a Europe-India cooperation? This is the theme of the last article of our new series on India’s health sector, by Christophe Jaffrelot, Senior Research Fellow at CERI-SciencesPo/CNRS, Vihang Jumle, Project Officer at TRAFFIC WWF India and Maitreyee Kishor, a Sciences Po graduate who works at Ashoka University's Centre for Writing and Communication.
Indian Pharma within Global Reach
2007
The Indian pharmaceutical industry is presently going through a phase of transition and potential consolidation, owing to India’s new TRIPS-compliant intellectual property regime and other rules aimed at enhancing the industry’s credibility nationally and internationally. Appropriate policy interventions can play a large role in cushioning the transition (and gradual consolidation) of the industry post-2005. Using firm level data collected in 2004-2005, this paper seeks to make two major contributions in this regard. The research findings show that the Indian pharmaceutical sector is a heterogeneous mix of firms with vast differences in innovative capabilities. Based on these differences, the groups can be categorized into specific “innovation modes ” (the innovator, the niche operator and the manufacturer), each mode being a step closer towards the innovative pharmaceutical firm. Second, the paper highlights how the emerging strategies of firms in all three groups, although differe...
stsistanbul.org. , 2020
Aybike Alkan and Öznur Karakaş interviewed Kaushik Sunder Rajan whom we had hosted in Istanbul in April 2019 as part of a series of events we organized. Sunder Rajan is faculty at Chicago University Anthropology Department and continues to study science and technology critically with a special focus on the political economies of life sciences and pharmaceuticals. After his first book (Biocapital, 2006) on the capitalist practices and discourses of the turn of the century genomic sciences in the US and India, Sunder Rajan published Pharmocracy that focuses on the political economy of health inequalities generated by the Big Pharma across the board. We believe that revisiting Sunder Rajan’s from his own words provides insight for studying and understanding the current pandemic we live by and the global inequalities regarding drug and vaccine R&D distribution from an STS lens in particular. Throughout the interview, Sunder Rajan discusses the nation-state and Euro-America centric tendencies that have been prevalent in STS intellectual genealogies and contributes to these discussions by bringing his own research background into the picture. He also talks about some of the scholars who had a deep influence on his own work both located in the US and India academic institutions with specific examples. Enjoy the read.
Empty stocks and loose paper: Governing access to medicines through informality in Northern India
International Sociology, 2018
Based upon research in the state of Bihar, India, this article argues that informal access to medicines in Northern India is a core element of the government of healthcare. Informal providers such as unlicensed village doctors and unlicensed drug sellers play a major role in access to medicines in Bihar, in the particular context of the dismantling of public procurement services. Building on recent works in the socio-anthropology of pharmaceuticals, the article shows the importance of taking into account the political economy of drugs in India, in order to understand local problems of access more fully. If informal providers occupy such an important position in the government of healthcare in India, this is partly due to the shaping of healthcare as access to drugs on health markets. Elaborating the argument from interviews with health professionals and patients, the article first shows the situation of public healthcare and public procurement in Bihar; then it presents the role of ...